Zinc protoporphyrin binding to telomerase complexes and inhibition of telomerase activity*

ABSTRACT: Abstract Zinc protoporphyrin (ZnPP), a naturally occurring metalloprotoporphyrin (MPP), is currently under development as a chemotherapeutic agent although its mechanism is unclear. When tested against other MPPs, ZnPP was the most effective DNA synthesis and cellular proliferation inhibitor while promoting apoptosis in telomerase positive but not telomerase negative cells. Concurrently, ZnPP down‐regulated telomerase expression and was the best overall inhibitor of telomerase activity in intact cells and cellular extracts with IC50 and EC50 values of ca 2.5 and 6 µM, respectively. The natural fluorescence properties of ZnPP enabled direct imaging in cellular fractions using non‐denaturing agarose gel electrophoresis, western blots, and confocal fluorescence microscopy. ZnPP localized to large cellular complexes (>600 kD) that contained telomerase and dysskerin as confirmed with immunocomplex mobility shift, immunoprecipitation, and immunoblot analyses. Confocal fluorescence studies showed that ZnPP co‐localized with telomerase reverse transcriptase (TERT) and telomeres in the nucleus of synchronized S‐phase cells. ZnPP also co‐localized with TERT in the perinuclear regions of log phase cells but did not co‐localize with telomeres on the ends of metaphase chromosomes, a site known to be devoid of telomerase complexes. Overall, these results suggest that ZnPP does not bind to telomeric sequences per se, but alternatively, interacts with other structural components of the telomerase complex to inhibit telomerase activity. In conclusion, ZnPP actively interferes with telomerase activity in neoplastic cells, thus promoting pro‐apoptotic and anti‐proliferative properties. These data support further development of natural or synthetic protoporphyrins for use as chemotherapeutic agents to augment current treatment protocols for neoplastic disease. ZnPP is a metalloprotoporphyrin that has been investigated as a potential chemotherapeutic agent. ZnPP was found to inhibit telomerase activity, bind to telomerase complexes, and co‐label telomerase and telomeres in situ. These data support further development of natural or synthetic protoporphyrins to augment current treatment protocols for neoplastic disease.

SUBMITTER: Zhu Z 

PROVIDER: S-EPMC8573827 | biostudies-literature |

REPOSITORIES: biostudies-literature